Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Tirzepatide for obesity without diabetes: mechanistic insights, clinical evidence, and future directions
Frontiers in pharmacology, 2026;17:1889594
The incretin-joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies
Rheumatology advances in practice, 2026;10(4):rkag105
Beyond Small Molecules: Applying Fragment Molecular Orbital Sygnature Platform (FMO-SP) to Emerging Modalities
Methods in molecular biology (Clifton, N.J.);3061:91-114
Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement
Cancer;132(16):e70586
Sex-based differences in clinical outcomes among patients with obesity and heart failure with preserved ejection fraction treated with tirzepatide
Therapeutic advances in cardiovascular disease, 2026;20:17539447261478928
Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial
Diabetes, obesity & metabolism, 2026
Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling
Molecular biomedicine, 2026;7(1)
Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis
Foot & ankle specialist, 2026;:19386400261471652
Letter: Non-Invasive Tests After Semaglutide in MASH as Disease-Activity Readouts Rather Than Response Biomarkers. Authors’ Reply
Alimentary pharmacology & therapeutics, 2026
Review Article: Fibrosis Reversal in Metabolic Dysfunction-Associated Steatohepatitis-The Promise of Emerging Therapeutics
Alimentary pharmacology & therapeutics, 2026
Maximizing weight loss with cagrisema: a systematic review and GRADE-assessed meta-analysis of randomized controlled trials
Naunyn-Schmiedeberg's archives of pharmacology, 2026
Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes
Diabetes, obesity & metabolism, 2026
Gastric content and aspiration risk after semaglutide cessation
Anaesthesia, 2026
Efficacy and Safety of Semaglutide in Patients with Polycystic Ovary Syndrome: A Scoping Review
Biomedicines, 2026;14(8)
Revisiting macrophage metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: mechanisms, regulation, and therapeutic breakthroughs
Frontiers in immunology, 2026;17:1899587
Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis
Endocrine, 2026;91(1)
Co-Agonism of GLP-1R and CTR/AMYR in the Lateral Dorsal Tegmental Nucleus Produces Additive Effects on Homeostatic and Motivated Feeding
Physiology & behavior, 2026;:115478
Investigating the Association Between Semaglutide Use and Mood Disorders in Polyendocrine Metabolic Ovarian Syndrome: A Retrospective Cohort Study
Cureus, 2026;18(8):e114569
Semaglutide treatment fails but might prevent Alzheimer’s disease
Lancet (London, England);408(10555):602-603
Liver Organoids: From Disease Modelling to Regenerative Medicine
Cell proliferation, 2026;:e70268